Scienture Holdings Inc.

Last updated September 27, 2026

Organization details

Legal name
Scienture Holdings Inc.
Former names
TRxADE HEALTH, INC Trxade Group, INC. Xcellink International INC. Bluebird Exploration Co.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Commack
Headquarters state / province
New York
Headquarters country
United States
Fiscal year end
December
Ticker symbol
SCNX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001382574

Board of directors

Chief executives

Surendra K. Ajjarapu · Chairman and CEO
Dates unknown
Hariharan Shankar · Co-CEO & Chairman
Dates unknown
Mani Narasimhan · President & Co-CEO
Dates unknown

Director election results

Annual meeting of March 10, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 6 other boards. 3 are in the same sector.

Network of Scienture Holdings Inc.'s board connections DataMeds AI Inc. DataMeds AI Inc. Aspire-Lakewood Holdings Inc. Aspire-Lakewood Holdin... Crown Reserve Acquisition Corp. I Crown Reserve Acquisit... Tevogen Inc. Tevogen Inc. Indonesia Energy Corporation Limited Indonesia Energy Corpo... Trio Petroleum Corp. Trio Petroleum Corp. Michael L. Peterson Michael L. Peterson Prashant Patel Prashant Patel Surendra K. Ajjarapu Surendra K. Ajjarapu Scienture Holdings Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Feb 20, 2026 Mani Narasimhan Director, Officer (President & Co-CEO) Grant or award +500,000 — —
Feb 20, 2026 Hariharan Shankar Director, Officer (Co-CEO & Chairman), 10% owner Grant or award +500,000 — —
Oct 1, 2025 Mani Narasimhan Director, Officer (President & Co-CEO) Grant or award +300,000 — —
Oct 1, 2025 Hariharan Shankar Director, Officer (Co-CEO & Chairman), 10% owner Grant or award +300,000 — —
May 15, 2025 Eric Michael Sherb Officer (Chief Financial Officer) Grant or award +50,000 — —
Apr 14, 2025 Mani Narasimhan Director, Officer (President & Co-CEO) Grant or award +750,000 — —
Apr 14, 2025 Hariharan Shankar Director, Officer (Co-CEO & Chairman), 10% owner Grant or award +750,000 — —
Mar 10, 2025 Mani Narasimhan Director, Officer (President & Co-CEO) Other −20,000 — —
Mar 10, 2025 Hariharan Shankar Director, Officer (Co-CEO & Chairman), 10% owner Other −30,000 — —
Sep 19, 2024 Hariharan Shankar Director, Officer (Co-CEO & Chairman), 10% owner Derivative conversion +1,916,816 — —
Sep 19, 2024 Mani Narasimhan Director, Officer (President & Co-CEO) Derivative conversion +1,357,538 — —
Sep 19, 2024 Hariharan Shankar Director, Officer (Co-CEO & Chairman), 10% owner Derivative conversion +356,480 — —
Jan 5, 2024 Prashant Patel Director, Officer (Interim CFO and Director) Grant or award +150,000 — —
Jan 5, 2024 Surendra K. Ajjarapu Director, Officer (Chairman and CEO) Grant or award +150,000 — —
Jan 16, 2023 Michael L. Peterson Director Grant or award +100,000 — —

Organizations in the same sector, closest in location and size first.

Questions about Scienture Holdings Inc.

Who is the CEO of Scienture Holdings Inc.?

Surendra K. Ajjarapu is Scienture Holdings Inc.'s Chairman and CEO.

How many directors are on Scienture Holdings Inc.'s board?

Scienture Holdings Inc.'s board has 5 directors: Hariharan Shankar, Mani Narasimhan, Michael L. Peterson, Prashant Patel and Surendra K. Ajjarapu.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="scienture-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.